Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

12 Aug 2014 07:00

RNS Number : 8156O
Oryx International Growth Fund Ld
12 August 2014
 



ORYX INTERNATIONAL GROWTH FUND LIMITED

INTERIM MANAGEMENT STATEMENT

FOR THE QUARTER ENDED 30 June 2014

 

 

Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FCA Handbook.

 

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 April 2014 to 30 June 2014, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Manager's Review

 

During the period under review, the FTSE Small Cap Index fell 2.6% and the FTSE All-Share Index returned 2.2%. Against this, the Company's net asset value decreased by 0.7%, to 537p per share. The Company has benefited from the recent improvement in market conditions resulting in an all-time high net asset value per share at 31 March 2014.

 

The company's largest unquoted holding, Celsius AG, is considering liquidity options and this may create further value for shareholders in the current financial year.

 

Material Transactions

There were no material transactions during the quarter ended 30 June 2014.

 

Material Events

There were no material events during the quarter ended 30 June 2014.

 

Report and Accounts

On 2 July 2014, the Company released its audited Annual Report and Financial Statements for the year ended 31 March 2014, to Shareholders.

 

Financial Highlights

 

30-Jun-14

31-Mar-14

31-Dec-13

30-Sep-13

30-Jun-13

31-Mar-13

31-Dec-12

NAV

£5.37

£5.41

£4.77

£4.32

£3.85

£3.78

£3.48

US Dollar /

Sterling Exchange Rate

1.7099

1.6672

1.6562

1.6194

1.5167

1.5182

1.6254

 

Twenty Largest Equity Investments at 30 June 2014

 

DETAILS

% of NET ASSETS

GLEESON (M.J.) GROUP PLC

14.22

GOALS SOCCER CENTRES PLC

8.73

QUARTO GROUP INC

5.57

OMG PLC

5.29

GUINNESS PEAT GROUP PLC

4.85

JOURNEY GROUP PLC

4.72

REDCENTRIC PLC

4.50

CELSIS AG

3.89

BIOQUELL PLC

3.49

TELECITY GROUP PLC

3.37

ACCUMULI PLC

3.29

ASSETCO PLC

3.11

ESSENDEN PLC

2.77

CATALYST MEDIA GROUP PLC

2.25

CYPROTEX PLC

1.89

WALKER CRIPS GROUP PLC

1.80

SOURCE BIOSCIENCE PLC

1.78

MECOM GROUP PLC

1.71

INNOVATION GROUP PLC

1.52

PROACTIS HOLDINGS PLC

1.51

TOTAL

80.26

 

 

The financial information for the quarter ended 30 June 2014 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

 

 

BNP Paribas Securities Services S.C.A., Guernsey Branch , for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGURARUPCGWG
Date   Source Headline
25th Oct 202112:09 pmRNSTransaction in Own Shares
11th Oct 202110:25 amRNSNet Asset Value(s)
23rd Sep 20214:32 pmRNSMajor liquidity events totalling £43 million
8th Sep 20212:13 pmRNSNet Asset Value(s)
27th Aug 202112:30 pmRNSResult of Annual General Meeting
9th Aug 20213:12 pmRNSNet Asset Value(s)
27th Jul 20216:00 pmRNSNotice of AGM
14th Jul 202111:45 amRNSNet Asset Value(s)
8th Jul 202111:42 amRNSAnnual Financial Report
9th Jun 20218:24 amRNSNet Asset Value(s)
3rd Jun 20212:44 pmRNSHolding(s) in Company - Replacement
3rd Jun 202112:51 pmRNSHolding(s) in Company
3rd Jun 20217:02 amRNSHolding(s) in Company
3rd Jun 20217:01 amRNSHolding(s) in Company
3rd Jun 20217:00 amRNSHolding(s) in Company
13th May 202111:21 amRNSNet Asset Value(s)
14th Apr 202111:42 amRNSNet Asset Value(s)
24th Mar 202110:26 amRNSHolding(s) in Company
22nd Mar 20216:27 pmRNSHolding(s) in Company
12th Mar 20213:37 pmRNSHolding(s) in Company
12th Mar 202111:01 amRNSNet Asset Value(s)
5th Mar 20219:02 amRNSHolding(s) in Company
4th Mar 202112:30 pmRNSHolding(s) in Company
1st Mar 20211:49 pmRNSTotal Voting Rights
26th Feb 20215:04 pmRNSHolding(s) in Company
25th Feb 20214:21 pmRNSHolding(s) in Company
17th Feb 20211:11 pmRNSHolding(s) in Company
12th Feb 202112:25 pmRNSTransaction in Own Shares
11th Feb 20216:00 pmRNSHolding(s) in Company
11th Feb 202110:49 amRNSNet Asset Value(s)
22nd Jan 20214:00 pmRNSHolding(s) in Company
22nd Jan 202111:09 amRNSHolding(s) in Company
20th Jan 20214:25 pmRNSNet Asset Value(s)
20th Jan 20219:50 amRNSHolding(s) in Company
18th Jan 20213:32 pmRNSHolding(s) in Company
15th Jan 20211:23 pmRNSHolding(s) in Company
4th Jan 20214:28 pmRNSTR-1: Notification of major holdings
4th Jan 20211:38 pmRNSTR1: Notification of major shareholding
4th Jan 202111:26 amRNSHoldings in Company
4th Jan 20217:30 amRNSHolding(s) in Company
31st Dec 20201:04 pmRNSTR-1
23rd Dec 202012:43 pmRNSHolding(s) in Company
21st Dec 20203:57 pmRNSNet Asset Value(s)
11th Dec 20201:05 pmRNSHolding(s) in Company
10th Dec 20201:55 pmRNSHalf-year Report
3rd Dec 20205:08 pmRNSTR-1
1st Dec 20204:41 pmRNSHolding(s) in Company
26th Nov 20201:08 pmRNSTR-1
25th Nov 20202:06 pmRNSHolding(s) in Company
23rd Nov 202012:25 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.